Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Molecular Pharmacology|March 19, 2017
Activation of the Orphan G Protein-Coupled Receptor GPR27 by Surrogate Ligands Promotes β-Arrestin 2 RecruitmentNadine Dupuis, Céline Laschet, Delphine Franssen, et al.
Cancers|April 3, 2021
CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6Andy Chevigné, Bassam Janji, Max Meyrath, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 24, 2022
The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A1-A2A receptor heteromer formation and functionLaura I Sarasola, Claudia Llinas Del Torrent, Andrea Pérez-Arévalo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2019
A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast CancerElin Sjöberg, Max Meyrath, Laura Milde, et al.
Frontiers in Immunology|August 9, 2023
GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunitySerena Melgrati, Oliver J Gerken, Marc Artinger, et al.
Chemmedchem|June 27, 2024
Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1Max E Huber, Silas L Wurnig, Aurélien F A Moumbock, et al.
Plos One|September 28, 2013
The proline-rich motif of the proDer p 3 allergen propeptide is crucial for protease-protease interactionMarie-Eve Dumez, Julie Herman, Vincenzo Campisi, et al.
Oncogene|August 8, 2018
Aurora A plays a dual role in migration and survival of human glioblastoma cells according to the CXCL12 concentrationEstelle Willems, Matthias Dedobbeleer, Marina Digregorio, et al.
The Journal of Biological Chemistry|August 30, 2008
Activation mechanism of recombinant Der p 3 allergen zymogen: contribution of cysteine protease Der p 1 and effect of propeptide glycosylationMarie-Eve Dumez, Nathalie Teller, Frédéric Mercier, et al.
European Journal of Medicinal Chemistry|September 6, 2022
Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseasesMaria Grazia Martina, Carmine Giorgio, Marika Allodi, et al.
Pageof 9